We are thrilled to share a major milestone for the Johns Hopkins Center for Psychedelic and Consciousness Research: @CeydaSayali, PhD, has received an R01 award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) — the first R01 awarded to an investigator at our Center. The study will test a novel treatment approach for alcohol use disorder (AUD) combining psilocybin with personalized repetitive transcranial magnetic stimulation (rTMS). This is the first study to investigate this combination for AUD, with rTMS targets individualized using fMRI to identify each participant’s brain circuitry involved in regulating alcohol craving. Using fMRI and TMS-EEG, the study will also examine how this combined intervention changes the neural mechanisms underlying craving, cognitive control, and treatment response. By integrating psychedelic pharmacology, personalized brain stimulation, and multimodal neuroscience, this work aims to advance both treatment development and our understanding of how brain-based interventions can reduce problematic alcohol use. Congratulations to Dr. Sayalı and the research team on this important achievement and exciting new direction for the Center.